Check Out Our Latest Edition! 

rmcover vol58i4


Latest New & Notable Products

 rmnn v58i4 nfl 

rmnn v58i4 excellence 

Solution Providers
rmsolution v58i4

newswirelogo

  • – Revenue Increases by 86% to $5.7 Million, Net Income up 30% to $3.0 Million –

  • NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Zoe’s Kitchen, Inc. (NYSE: ZOES) on behalf of stockholders concerning the proposed acquisition of the company by Cava Group.

  • REDWOOD CITY, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective August 14, 2018, the company’s board of directors granted 3 new employees options to purchase an aggregate of 35,500 shares of the company’s common stock with a per share exercise price of $19.40, the closing trading price on the grant date. The company also announced that the company’s board of directors granted one new employee and a Vice President, Drug Safety and Pharmacovigilance, options to purchase 20,000 and 40,000 shares of the company’s common stock, respectively, with a per share exercise price of $18.75, the closing trading price on August 16, 2018, their hiring date. The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the company.

  • SANTA BARBARA, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on August 16, 2018, the Compensation Committee of the Board of Directors approved equity award grants under the Sientra Inc. Inducement Plan to 41 new employees, including to 22 new employees at the Company’s miraDry subsidiary.

  • AUSTIN, Texas, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced the closing of its previously announced registered direct offering of 8,860,778 shares of its common stock, which was priced at-the-market at a purchase price of $1.15 per share, for gross proceeds of approximately $10.19 million.  

Contact Us

Retail Merchandiser Magazine
150 N. Michigan Ave., Suite 900
Chicago, IL 60601

  312.676.1100
  312.676.1101

Click here for a full list of contacts.

Latest Edition

Spread The Love

Back To Top